Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 6 | $143,558 |
Sells | 26 | $231,774 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
08 Aug 2022 16:14 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 05 Aug 2022 | Purchase | 8,606 | 5.8041 | 49,950 | D |
19 Jan 2023 16:58 | ESPR | Esperion Therapeutics Inc | LOOKER BENJAMIN | General Counsel | 18 Jan 2023 | Sale | 6,347 | 6.996 | 44,404 | D |
11 May 2023 16:11 | ESPR | Esperion Therapeutics Inc | CARROLL J MARTIN | Director | 11 May 2023 | Purchase | 23,091 | 1.5714 | 36,285 | D |
08 Mar 2023 16:21 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 07 Mar 2023 | Sale | 5,441 | 5.056 | 27,510 | D |
08 Mar 2023 16:22 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 07 Mar 2023 | Sale | 5,090 | 5.055 | 25,730 | D |
20 Jul 2022 16:27 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 19 Jul 2022 | Sale | 3,901 | 6.55 | 25,552 | D |
10 May 2023 16:12 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 09 May 2023 | Purchase | 20,000 | 1.2596 | 25,192 | D |
20 Sep 2022 16:08 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 19 Sep 2022 | Sale | 3,394 | 6.938 | 23,548 | D |
08 Mar 2023 16:20 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 07 Mar 2023 | Sale | 3,884 | 5.065 | 19,672 | D |
11 May 2023 16:11 | ESPR | Esperion Therapeutics Inc | CARROLL J MARTIN | Director | 10 May 2023 | Purchase | 8,409 | 1.4919 | 12,545 | D |
20 Mar 2023 16:16 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 17 Mar 2023 | Sale | 6,999 | 1.783 | 12,479 | D |
11 May 2023 16:10 | ESPR | Esperion Therapeutics Inc | ROCAMBOLI STEPHEN | Director | 10 May 2023 | Purchase | 8,111 | 1.495 | 12,126 | D |
20 Jun 2024 16:20 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 18 Jun 2024 | Sale | 3,285 | 2.867 | 9,418 | D |
19 Jan 2023 16:58 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 18 Jan 2023 | Sale | 1,191 | 6.985 | 8,319 | D |
31 Aug 2022 16:14 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 31 Aug 2022 | Purchase | 1,000 | 7.46 | 7,460 | D |
20 Jun 2024 16:16 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 18 Jun 2024 | Sale | 2,540 | 2.856 | 7,254 | D |
19 Oct 2022 16:13 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 18 Oct 2022 | Sale | 942 | 7.688 | 7,242 | D |
20 Mar 2023 16:19 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 17 Mar 2023 | Sale | 3,808 | 1.7819 | 6,785 | D |
20 Jul 2022 16:27 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Jul 2022 | Sale | 431 | 6.582 | 2,837 | D |
20 Sep 2022 16:09 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Sep 2022 | Sale | 255 | 6.921 | 1,765 | D |
20 Apr 2023 16:12 | ESPR | Esperion Therapeutics Inc | LOOKER BENJAMIN | General Counsel | 19 Apr 2023 | Sale | 1,290 | 1.272 | 1,641 | D |
18 Aug 2022 16:10 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Aug 2022 | Sale | 199 | 6.815 | 1,356 | D |
20 Apr 2023 16:11 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 19 Apr 2023 | Sale | 938 | 1.271 | 1,192 | D |
20 Mar 2023 16:16 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Mar 2023 | Sale | 526 | 1.7823 | 937 | D |
21 Sep 2023 17:06 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 20 Sep 2023 | Sale | 742 | 1.245 | 924 | D |
22 Jun 2023 16:45 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 21 Jun 2023 | Sale | 603 | 1.483 | 894 | D |
19 Oct 2022 16:11 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 18 Oct 2022 | Sale | 107 | 7.69 | 823 | D |
20 May 2024 16:14 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 May 2024 | Sale | 192 | 2.483 | 477 | D |
18 May 2023 16:07 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 May 2023 | Sale | 219 | 1.624 | 356 | D |
21 Aug 2023 16:32 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 18 Aug 2023 | Sale | 243 | 1.414 | 344 | D |
20 Jul 2023 16:38 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Jul 2023 | Sale | 106 | 1.585 | 168 | D |
20 Apr 2023 16:12 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Apr 2023 | Sale | 115 | 1.278 | 147 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)